CRSP Competitors & Alternatives
Compare Crispr Therapeutics AG with similar stocks in the same industry
Biotechnology
CRSP
Main Stock$40.61
-3.86%
Tradestie Score
49
Market Cap
$6.02B
Revenue Growth
13.3%
Analyst Upside
+110.3%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 4/10
Genomics Precision Med
Gene Editing
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
+0.03%
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$125.40
-4.24%
|
$3.98B | 28.1 | 42 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
+0.13%
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$124.79
-2.18%
|
$3.91B | - | 47 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$23.74
-3.50%
|
$3.83B | - | 44 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$13.43
-8.14%
|
$3.68B | - | 51 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$92.92
-1.14%
|
$3.67B | - | 38 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$13.70
+0.11%
|
$3.59B | 17.2 | 28 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.07
+1.71%
|
$3.58B | 8.6 | 47 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$304.93
-1.25%
|
$3.49B | 127.0 | 45 | Compare |
More CRSP Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry